Award-Winning Strategy

With over two decades in business, LaVoieHealthSceince has been honored with 50+ investor relations and public relations awards as well as rated consistently as one of the top healthcare PR firms in the country and one of the largest PR firms in Massachusetts.

2023 | PR Week Best in Healthcare Innovation Finalist

2023 | Menarini | Healthcare Campaign | Paving the Way: An FDA Approval of OSERDU (elacestrant) for Advanced or Metastatic Breast Cancer | Bronze Bell Ringer Winner

2020-2022 | Agency Elite 100

2022 | Outlook Therapeutics | Brand Building or Re-Branding B2B Campaign | Reputation Building and Market-Shaping for an Ophthalmic Bevacizumab in Retinal Disease | Silver Bell Ringer

2022 | BBJ Fast50

2022 | Insights Care Magazine

2022 | Top Healthcare PR Firms

2021 | MarCom Gold Award
Vectors Gone Viral; Episodic Social Series on Viral Vectors for Gene and Cell Therapy, and Vaccine Development

2021 | BBJ Fast50

2021 | Sharon Correia, Mentor, Ragan’s Top Women in Communications

2021 | TFF Pharmaceuticals | Building Investor Visibility and Credibility, Post-IPO | Silver Bell Ringer Winner

2021 | MarCom Platinum Award
Visus Therapeutics Inaugural Capital Markets Day

2021 | Top Healthcare PR Firms

2020 | PharmaVOICE 100 |
Donna LaVoie, President, CEO & Founder

2020 | Top Healthcare PR Firms